InvestorsHub Logo
Followers 31
Posts 3757
Boards Moderated 0
Alias Born 01/29/2012

Re: chickpea598 post# 39482

Thursday, 06/22/2017 3:08:30 PM

Thursday, June 22, 2017 3:08:30 PM

Post# of 48316

Could sweeten the buyout potential in my opinion.


I agree that any validation of these patents through data will increase ONCS's enterprise value if time comes for a buyout. I hope they get some traction on these by the time interim data from the melanoma registration trial is released. It would be sad if these are not properly valued in a potential buyout offer, whenever that may be.